615. Is Ozempic as Magical as It Sounds?
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.
- Duration
- 1h 4m
- Broadcast on
- 11 Dec 2024
- Audio Format
- other
This episode appears to contain dynamically inserted ads. Transcript timestamps may be approximate.
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.
- SOURCES:
- Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine.
- RESOURCES:
- "Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal," by Margot Sanger-Katz (The New York Times, 2024).
- "International Coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches," by Johan L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel (The Lancet, 2024).
- The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma, by Mustafa Suleyman (2023).
- "The Significance of Blockbusters in the Pharmaceutical Industry," by Alexander Schuhmacher, Markus Hinder, Nikolaj Boger, Dominik Hartl, and Oliver Gassmann (Nature Reviews Drug Discovery, 2022).
- Reinventing American Health Care: How the Affordable Care Act Will Improve Our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System, by Ezekiel J. Emanuel (2014).
- "Why I Hope to Die at 75," by Ezekiel J. Emanuel (The Atlantic, 2014).
- "Direct-to-Consumer Advertising of Pharmaceuticals," by Ziad F. Gellad and Kenneth W. Lyles (The American Journal of Medicine, 2014).
- Brothers Emanuel: A Memoir of an American Family, by Ezekiel J. Emanuel (2013).
- "Bounds in Competing Risks Models and the War on Cancer," by Bo E. Honoré and Adriana Lleras-Muney (Econometrica, 2006).
- EXTRAS:
- "How to Fix Medical Research," by People I (Mostly) Admire (2024).
- "The Suddenly Diplomatic Rahm Emanuel," by Freakonomics Radio (2023).
- "Ari Emanuel Is Never Indifferent," by Freakonomics Radio (2023).
- "Who Pays for Multimillion-Dollar Miracle Cures?" by Freakonomics, M.D. (2023).
- "Who Gets the Ventilator?" by Freakonomics Radio (2020).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Preeconomic radio is sponsored by Everpure. Is the value of AI not living up to the promise? The problem is probably your data, not your AI models. When it's scattered across different systems, getting your data AI ready is a challenge. You keep your AI waiting and everything slows down. Everpure unifies your data so you can see it, understand it and control it all from one simple place and get it AI-ready fast. Unlock the true value of your AI at EverpureData.com. Preeconomic radio is sponsored by E-Trade for Morgan Stanley. Simplify your finances and discover the convenience of investing in banking all in one place. Plus get up to $1,500 when you open a brokerage account with a qualifying deposit today. Learn more at e-trade.com/offer. Banking products and services are provided by Morgan Stanley Private Bank, National Association Member FDIC, Terms and other fees apply. Investing involves risks, Morgan Stanley, Smith Barney, LLC, Member, SIPC. Preeconomic radio is sponsored by Amica. You know what they say. If you want to go fast, go alone. If you want to go far, go together. So go with Amica and get coverage from a mutual insurer that's built for their customers. And that looks after what's important to you together. Auto, home, life and more coverage that fits your unique needs, Amica helps you protect what matters most, visit amica.com and get a quote today. Preeconomic radio is sponsored by Mint Mobile. With Mint Mobile's summer sale, all of Mint's plans are $15 per month, even unlimited. Free yourself from big wireless and switch to Mint for high-speed data and coverage on the T-Mobile 5G network. To get your new wireless plan for just $15 a month, go to mintmobile.com/freak. That's mintmobile.com/freak. Upfront payment, $45 for three months, $90 for six months or $180 for 12 months. Plan required, $15 per month equivalent. Taxes and fees extra initial plan term only. Later than 50 gigabytes may slow when network is busy, includes up to 20 gigabytes hotspot. Capable device required, availability, speed and coverage varies, see Mint Mobile.com. The United States is one of just two countries that allow pharmaceutical firms to freely advertise their products directly to consumers. The other is New Zealand. So if you ever watch TV in the US, you have likely seen many ads for prescription drugs. But advertising doesn't guarantee success. The research and development of these drugs is very expensive and most of them never earn back their investment. The pharmaceutical industry, therefore, relies on the occasional blockbuster drug. A blockbuster defined is doing more than a billion dollars a year in sales. If I asked you to name a blockbuster drug from the past, you might say Lipitor, a statin originally from Park Davis, or Humera, an anti-inflammatory, now sold by Abbe. And can you name a current blockbuster? The first drug that comes to mind might be this one. If you watch even a tiny bit of TV, you've probably seen an ad for Ozempic. Your jingle is sung to the tune of the 1974 pop hit magic by a band called Pilot, which had exactly one US hit.
Transcription truncated.
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.